Form 8-K - Current report:
SEC Accession No. 0001326110-25-000084
Filing Date
2025-06-20
Accepted
2025-06-20 16:39:24
Documents
13
Period of Report
2025-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibrx-20250618.htm   iXBRL 8-K 56110
2 EX-10.1 ibrx-2025620x8xkexhibit101.htm EX-10.1 207231
  Complete submission text file 0001326110-25-000084.txt   415706

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20250618.xsd EX-101.SCH 1866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20250618_lab.xml EX-101.LAB 21876
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20250618_pre.xml EX-101.PRE 12585
15 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20250618_htm.xml XML 2815
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 251061996
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)